CLBIO — Corline Biomedical AB Share Price
0.000.00%
Last trade - 00:00- SEK199.86m
- SEK182.20m
- SEK9.78m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.42 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.3 | ||
| Price to Tang. Book | 14.9 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 20.45 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -26.65% | ||
| Return on Equity | -25.74% | ||
| Operating Margin | -236.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 3.7 | 7.06 | 23.55 | 25.03 | 9.78 | 28.5 | 43 | 55.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +85.32 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 24th, 1991
- Public Since
- June 3rd, 2015
- No. of Employees
- 13
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 21,490,819
- Address
- Lefflersgatan 5, UPPSALA, 75450
- Web
- https://www.corline.se/home
- Phone
- +46 1871346946
- Auditors
- PricewaterhouseCoopers AB
Upcoming Events for CLBIO
Corline Biomedical AB Annual Shareholders Meeting
Q2 2025 Corline Biomedical AB Earnings Release
Similar to CLBIO
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
Dicot Pharma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Corline Biomedical AB share price?
As of Today at 20:04 UTC, shares in Corline Biomedical AB are trading at SEK9.30. This share price information is delayed by 15 minutes.
How has the Corline Biomedical AB share price performed this year?
Shares in Corline Biomedical AB last closed at SEK9.30 and the price had moved by -8.82% over the past 365 days. In terms of relative price strength the Corline Biomedical AB share price has underperformed the FTSE Global All Cap Index by -11.11% over the past year.
What are the analyst and broker recommendations for Corline Biomedical AB?
There is no consensus recommendation for this security.
Find out moreWhat is the Corline Biomedical AB dividend yield?
Corline Biomedical AB does not currently pay a dividend.
Does Corline Biomedical AB pay a dividend?
Corline Biomedical AB does not currently pay a dividend.
When does Corline Biomedical AB next pay dividends?
Corline Biomedical AB does not currently pay a dividend.
How do I buy Corline Biomedical AB shares?
To buy shares in Corline Biomedical AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Corline Biomedical AB?
As of the previous close price of SEK9.30, shares in Corline Biomedical AB had a market capitalisation of SEK199.86m.
Where are Corline Biomedical AB shares listed?
Here are the trading details for Corline Biomedical AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CLBIO
What kind of share is Corline Biomedical AB?
Based on an overall assessment of its quality, value and momentum Corline Biomedical AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Corline Biomedical AB share price forecast for 2025?
The analyst consensus target price for shares in Corline Biomedical AB is SEK20.50. That is 120.43% above the last closing price of SEK9.30.
Analysts covering Corline Biomedical AB currently have a consensus Earnings Per Share (EPS) forecast of SEK0.55 for the next financial year.
Find out moreWhat is the trend in the Corline Biomedical AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Corline Biomedical AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +9.27%.
As of the last closing price of SEK9.30, shares in Corline Biomedical AB were trading -1.13% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Corline Biomedical AB PE Ratio?
The Corline Biomedical AB PE ratio based on its reported earnings over the past 12 months is 13.42. The shares last closed at SEK9.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Corline Biomedical AB?
We do not have data on Corline Biomedical AB's directors